Proprotein convertases promote processing of VEGF‐D, a critical step for binding the angiogenic receptor VEGFR‐2
- 16 January 2007
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 21 (4) , 1088-1098
- https://doi.org/10.1096/fj.06-7060com
Abstract
Vascular endothelial growth factor (VEGF)-D is a secreted glycoprotein that induces angiogenesis and lymphangiogenesis. It consists of a central domain, containing binding sites for VEGF receptor-2 (VEGFR-2) and VEGFR-3, and N- and C-terminal propeptides. It is secreted from the cell as homodimers of the full-length form that can be proteolytically processed to remove the propeptides. It was recently shown, using adenoviral gene delivery, that fully processed VEGF-D induces angiogenesis in vivo, whereas full-length VEGF-D does not. To better understand these observations, we monitored the effect of VEGF-D processing on receptor binding using a full-length VEGF-D mutant that cannot be processed. This mutant binds VEGFR-2, the receptor signaling for angiogenesis, with ∼17,000-fold lower affinity than mature VEGF-D, indicating the importance of processing for interaction with this receptor. Further, we show that members of the proprotein convertase (PC) family of proteases promote VEGF-D processing, which facilitates the VEGF-D/VEGFR-2 interaction. The PCs furin and PC5 promote cleavage of both propeptides, whereas PC7 promotes cleavage of the C-terminal propeptide only. The finding that PCs promote activation of VEGF-D and other proteins with roles in cancer such as matrix metalloproteinases, emphasizes the importance of these enzymes as potential regulators of tumor progression and metastasis.—McColl, B. K., Paavonen, K., Karnezis, T., Harris, N. C., Davydova, N., Rothacker, J., Nice, E. C., Harder, K. W., Roufail, S., Hibbs, M. L., Rogers, P. A. W., Alitalo, K., Stacker, S. A., Achen, M. G. Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2.Keywords
Funding Information
- National Health and Medical Research Council
This publication has 55 references indexed in Scilit:
- The biology of vascular endothelial growth factorsPublished by Oxford University Press (OUP) ,2005
- Focus on lymphangiogenesis in tumor metastasisCancer Cell, 2005
- VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via AdenovirusesCirculation Research, 2003
- Adenovirus encoding vascular endothelial growth factor–D induces tissue-specific vascular patterns in vivoBlood, 2002
- Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic miceThe EMBO Journal, 2001
- VEGF-D promotes the metastatic spread of tumor cells via the lymphaticsNature Medicine, 2001
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Proceedings of the National Academy of Sciences, 1998
- Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.Proceedings of the National Academy of Sciences, 1996
- Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.Proceedings of the National Academy of Sciences, 1995
- High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesisCell, 1993